Phelix Medical LLC
Phelix Medical is dedicated to revolutionizing healthcare through personalized medicine, focusing on Pharmacogenomics (PGx) testing. Their mission is to bridge healthcare disparities and provide innovative, individualized treatment options tailored to the unique needs of every patient. They specialize in areas such as Minority Health, Mental Health, and Senior Care, aiming to optimize treatment plans, reduce adverse drug reactions, and enhance overall health outcomes.
Industries
N/A
Nr. of Employees
small (1-50)
Products
PGx sample collection kit
A non‑invasive cheek swab kit designed to collect DNA for pharmacogenomic analysis.
PGx sample collection kit
A non‑invasive cheek swab kit designed to collect DNA for pharmacogenomic analysis.
Services
End-to-end PGx testing service including kit distribution, sample collection (cheek swab), laboratory analysis, and clinical reporting to guide medication selection.
Support for healthcare providers to integrate PGx testing into clinical workflows, including training on result interpretation and ongoing support.
Services to integrate pharmacogenomic testing into employer health benefits and payor programs, including educational resources and population-level data insights.
End-to-end PGx testing service including kit distribution, sample collection (cheek swab), laboratory analysis, and clinical reporting to guide medication selection.
Support for healthcare providers to integrate PGx testing into clinical workflows, including training on result interpretation and ongoing support.
Services to integrate pharmacogenomic testing into employer health benefits and payor programs, including educational resources and population-level data insights.
Expertise Areas
- Pharmacogenomics testing
- Clinical implementation of pharmacogenomics
- Medication optimization and genotype-guided dosing
- PGx applications for mental health
Key Technologies
- Genotyping of pharmacogenetic markers
- Cheek‑swab DNA collection
- Clinical laboratory genetic analysis
- Variant interpretation for pharmacogenomics